Phase 1 Clinical Trials: What Sponsors and CROs Need to Know
Before any drug reaches the market or even moves to large-scale testing, it has to pass one critical checkpoint: Phase 1. This is where it all begins. For sponsors and CROs, Phase 1 trials set the foundation for everything that follows. They’re high-stakes, time-sensitive, and tightly regulated. Small mistakes here can delay entire development programs or compromise […]